AVE 25.0% 0.3¢ avecho biotechnology limited

The veterinary product under development with a third party may...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,893 Posts.
    lightbulb Created with Sketch. 606
    The veterinary product under development with a third party may be propofol or it could be something else.Even if it is not profotol at this time the vetinary use of propofol is extensive and surely must be of interest to AVE if not Terumo.​

    Aparently in some countries propofol is only approved for vetinary use:The following list of vetinary products approved for use in various countries ​
    is just a random selection as follows:​

    Proposure[UK]​

    Aquafol[Australia]​

    Naarcofol[Germany]​

    Norofol[UK]​

    Propo Clear[US]​

    Propo[Netherlands]​

    Propoflo[US]​

    Propoflo Plus[UK]​

    Vetofol[France] ​

    Just to pick one product from the above list[just because it was easy] vetofol is manufactured by Norbrook Laboratories in Ireland [a vetinary product only pharma manufacturer].This type of pharma could be interested in the companys current propofol research. ​

    Kens ​
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.